Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Developed by Eli Lilly, it is a single-molecule triple receptor agonist targeting three key metabolic hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Ginsenoside Rg1 treatment ameliorated sepsis-induced AKI by reducing iron deposition and lipid peroxidation and elevating the expression of GPX4 and FSP1
No, needles and syringes should never be reused
[Abstract] J Am Chem Soc
Brain region-specific glutathione redox imbalance in autism
US$ 28.54
US$ 26.49
US$ 24.30
US$ 23.33
US$ 24.45
